v3.26.1
Note 20 - Parent Only Condensed Financial Statements - Condensed Statements of Cash Flows (Details) - USD ($)
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Net Income $ 29,617,000 $ 28,619,000 $ 29,776,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Stock-based compensation expense 343,000 502,000 322,000
(Increase) decrease in accrued interest receivable and other assets (5,285,000) 1,690,000 335,000
Net cash provided by operating activities 21,587,000 30,509,000 38,338,000
Cash flows from financing activities:      
Cash dividends paid on common stock (7,720,000) (6,365,000) (5,862,000)
Redemption of Trust Preferred Securities 0 0 (10,310,000)
Repayments on other borrowings (20,750,000) (185,000,000) 0
Increase in other borrowings 0 110,000,000 90,000,000
Proceeds from exercise of stock options 1,105,000 508,000 339,000
Net cash used in provided by financing activities (93,307,000) (44,392,000) (45,557,000)
Cash flows from investing activities:      
Decrease in cash and cash equivalents (1,402,000) (3,637,000) (97,771,000)
Cash and cash equivalents at beginning of year 82,018,000 85,655,000 183,426,000
Cash and cash equivalents at end of year 80,616,000 82,018,000 85,655,000
Parent Company [Member]      
Net Income 29,617,000 28,619,000 29,776,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Equity in undistributed income of bank subsidiary (4,708,000) (19,462,000) (21,746,000)
Stock-based compensation expense 80,000 174,000 78,000
Amortization of discount on borrowings 142,000 0 0
(Increase) decrease in accrued interest receivable and other assets (56,000) 94,000 554,000
(Decrease) increase in other liabilities (51,000) 85,000 (185,000)
Net cash provided by operating activities 25,024,000 9,510,000 8,477,000
Cash flows from financing activities:      
Cash dividends paid on common stock (7,720,000) (6,365,000) (5,862,000)
Redemption of Trust Preferred Securities 0 0 (10,310,000)
Repayments on other borrowings (5,750,000) 0 0
Increase in other borrowings 0 5,000,000 10,000,000
Proceeds from exercise of stock options 1,105,000 508,000 339,000
Net cash used in provided by financing activities (12,365,000) (857,000) (5,833,000)
Cash flows from investing activities:      
Cash paid in acquisition (15,514,000) 0 0
Decrease in cash and cash equivalents (2,855,000) 8,653,000 2,644,000
Cash and cash equivalents at beginning of year 12,261,000 3,608,000 964,000
Cash and cash equivalents at end of year $ 9,406,000 $ 12,261,000 $ 3,608,000